Key Points
- 1Prospective dual-cohort study from Iran comparing incident T2DM, hypertension, and dyslipidaemia in bariatric surgery (n=612) versus obese controls (n=593) over three years; impressive risk reductions, but non-randomised allocation and baseline metabolic imbalance between cohorts limit causal attribution.
